相关实验视频
Updated: Jul 24, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Published on: February 23, 2024
个性化精准医学:患有AML的患者对治疗决策的看法
Åsa Grauman1, Mika Kontro2, Karl Haller3
1Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.
患有急性髓性白血病的患者希望获得更多信息,以便在精准医学中共同做出决策. 缺乏知识阻碍了参与,强调了医生.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 医学伦理 医学伦理
背景情况:
- 急性髓性白血病 (AML) 提出了复杂的治疗决策.
- 精准医学为AML提供个性化的治疗策略.
- 患者参与共享决策正在不断发展.
研究的目的:
- 探索AML患者对精准医学的看法.
- 了解患者对参与精准医学决策的偏好.
- 确定患者参与的障碍和促进者.
主要方法:
- 在三个欧洲国家 (芬兰,意大利,德国) 进行的半结构面试.
- 研究包括16名年龄在24-79岁之间的患者.
- 用于分析采访数据的专题内容分析.
主要成果:
- 患者认为缺乏知识是决策的重要障碍.
- 治疗选择通常基于医生的信任和直觉,特别是在紧急情况下.
- 患者表示愿意接受治疗,由于他们的危急状况,治愈概率很低.
结论:
- 患者对精准医学的理解和参与决策构成重大挑战.
- 虽然欢迎技术进步,但作为一个值得信赖的专家,医生的作用仍然至关重要.
- 有效的患者教育对于提高人们对精准医学感知的参与至关重要.
更多相关视频
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
10:28Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Treatment Resistant Cancers
Cancer Survival Analysis
Patient-centered Care